AAAAAA

   
Results: 1-11 |
Results: 11
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection
Authors: Garcia, F Plana, M Ortiz, GM Bonhoeffer, S Soriano, A Vidal, C Cruceta, A Arnedo, M Gil, C Pantaleo, G Pumarola, T Gallart, T Nixon, DF Miro, JM Gatell, JM
Citation: F. Garcia et al., The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection, AIDS, 15(9), 2001, pp. F29-F40
Predictors of progression in chronically infected naive patients with plasma viraemia below 5000 copies/ml and CD4 T lymphocytes greater than 500 x 10(6)/l
Authors: Garcia, F Plana, M Soriano, A Vidal, C Arnedo, M Gil, C Cruceta, A Pumarola, T Gallart, T Miro, JM Gatell, JM
Citation: F. Garcia et al., Predictors of progression in chronically infected naive patients with plasma viraemia below 5000 copies/ml and CD4 T lymphocytes greater than 500 x 10(6)/l, AIDS, 15(1), 2001, pp. 131-133
The carboxy-terminal domain of Grp94 binds to protein kinase CK2 alpha butnot to CK2 holoenzyme
Authors: Roher, N Sarno, S Miro, F Ruzzene, M Llorens, F Meggio, F Itarte, E Pinna, LA Plana, M
Citation: N. Roher et al., The carboxy-terminal domain of Grp94 binds to protein kinase CK2 alpha butnot to CK2 holoenzyme, FEBS LETTER, 505(1), 2001, pp. 42-46
The C-terminal domain of human grp94 protects the catalytic subunit of protein kinase CK2 (CK2 alpha) against thermal aggregation - Role of disulfidebonds
Authors: Roher, N Miro, F Boldyreff, B Llorens, F Plana, M Issinger, OG Itarte, E
Citation: N. Roher et al., The C-terminal domain of human grp94 protects the catalytic subunit of protein kinase CK2 (CK2 alpha) against thermal aggregation - Role of disulfidebonds, EUR J BIOCH, 268(2), 2001, pp. 429-436
Residual low-level viral replication could explain discrepancies between viral load and CD4(+) cell response in human immunodeficiency virus-infectedpatients receiving antiretroviral therapy
Authors: Garcia, F Vidal, C Plana, M Cruceta, A Gallart, MT Pumarola, T Miro, JM Gatell, JM
Citation: F. Garcia et al., Residual low-level viral replication could explain discrepancies between viral load and CD4(+) cell response in human immunodeficiency virus-infectedpatients receiving antiretroviral therapy, CLIN INF D, 30(2), 2000, pp. 392-394
Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection
Authors: Plana, M Garcia, F Gallart, T Tortajada, C Soriano, A Palou, E Maleno, MJ Barcelo, JJ Vidal, C Cruceta, A Miro, JM Gatell, JM
Citation: M. Plana et al., Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection, AIDS, 14(13), 2000, pp. 1921-1933
Land issues in the region of La Laguna during the Mexican Revolution
Authors: Plana, M
Citation: M. Plana, Land issues in the region of La Laguna during the Mexican Revolution, HIST MEX, 50(1), 2000, pp. 57-90
Association of protein kinase CK2 with eukaryotic translation initiation factor eIF-2 and with grp94/endoplasmin
Authors: Riera, M Roher, N Miro, F Gil, C Trujillo, R Aguilera, J Plana, M Itarte, E
Citation: M. Riera et al., Association of protein kinase CK2 with eukaryotic translation initiation factor eIF-2 and with grp94/endoplasmin, MOL C BIOCH, 191(1-2), 1999, pp. 97-104
Multiple forms of protein kinase CK2 present in leukemic cells: In vitro study of its origin by proteolysis
Authors: Roig, J Krehan, A Colomer, D Pyerin, W Itarte, E Plana, M
Citation: J. Roig et al., Multiple forms of protein kinase CK2 present in leukemic cells: In vitro study of its origin by proteolysis, MOL C BIOCH, 191(1-2), 1999, pp. 229-234
Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication
Authors: Garcia, F Niebla, G Romeu, J Vidal, C Plana, M Ortega, M Ruiz, L Gallart, T Clotet, B Miro, JM Pumarola, T Gatell, JM
Citation: F. Garcia et al., Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication, AIDS, 13(12), 1999, pp. 1491-1496
Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy
Authors: Garcia, F Plana, M Vidal, C Cruceta, A O'Brien, WA Pantaleo, G Pumarola, T Gallart, T Miro, JM Gatell, JM
Citation: F. Garcia et al., Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy, AIDS, 13(11), 1999, pp. F79-F86
Risultati: 1-11 |